For chronic obstructive pulmonary disease (COPD), pulmonary hypertension and other pulmonary disorders, lung transplant may not be the appropriate treatment. Depth of expertise and knowledge allow Washington University pulmonologists and thoracic surgeons at Barnes-Jewish Hospital to offer a range of treatment options to patients, outlined below.
Innovative Lung Volume Reduction Surgery
Barnes-Jewish Hospital is a national leader in lung volume reduction surgery
to treat chronic obstructive pulmonary disease (COPD).
Lung volume reduction surgery is an innovative emphysema treatment that removes 20 to 30 percent of the lung tissue most damaged by emphysema. This allows the remaining, less diseased, portion of the lung more room to function, resulting in easier breathing.
The surgery is performed through a breastbone incision or by video-assisted technique. The bilateral surgery, in which tissue is removed from both lungs, results in greater improvement than single-lung surgery and avoids the need for a second, later surgery on the other lung.
Lung volume reduction surgery is not a cure, but in select patients, the procedure provides an alternative to a lung transplant. It also is appropriate for patients who are not eligible for lung transplantation. The goal is to return patients to the lung function they had about five years previously. Patients must have severe emphysema and meet strict requirements to be considered a candidate for the surgery.
Pulmonary Hypertension Clinic
The Washington University pulmonary hypertension service at Barnes-Jewish Hospital provides comprehensive evaluation of patients and ongoing care for patients with pulmonary arterial hypertension. The clinic, which currently follows about 150 patients, is the only specialized clinic within a several hundred-mile radius. Our patients originate from surrounding states.
The pulmonary hypertension team includes physicians and advance practice nurses with expertise in pulmonary vascular diseases. We offer all FDA-approved medical therapies, including intravenous, subcutaneous, and inhaled agents; and we collaborate with our cardio-thoracic surgeons and interventional cardiologists to provide surgical treatments, such as thoracic transplantation, atrial septostomy, and pulmonary thromboendarterectomy.
With the assistance of the Center for Clinical Studies at Washington University, we also participate in numerous multi-center clinical investigations with the latest, cutting-edge therapies, including agents yet to be FDA-approved.
For more information on the lung transplant program at Barnes-Jewish Hospital, call